Is Besponsa included in the medical insurance?

Besponsa/Besponsa has not yet been included in the national medical insurance. Since the drug has been on the market in China for a short time and is very expensive, patients are still unable to enjoy medical insurance reimbursement. Specific reimbursement policies may vary due to changes in regions and medical insurance policies. It is recommended to directly consult the local medical insurance department or relevant medical institutions to obtain the most accurate information. Oxinutuzumab/Ointuzumab is a drug mainly used to treat B-cell Acute Lymphoblastic Leukemia (B-ALL) in adults. It is a monoclonal antibody drug whose mechanism of action is to interfere with the growth and survival of leukemia cells by targeting the CD22 antigen on the surface of lymphocytes.